Filing Details

Accession Number:
0000919574-19-004138
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-06-13 17:15:13
Reporting Period:
2019-06-11
Accepted Time:
2019-06-13 17:15:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
949858 Achieve Life Sciences Inc. ACHV In Vitro & In Vivo Diagnostic Substances (2835) 954343413
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1601086 Armistice Capital, Llc 510 Madison Avenue, 7Th Floor
New York NY 10022
No No Yes No
1633584 Ltd. Fund Master Capital Armistice C/o Dms Corporate Services Ltd.
20 Genesis Close, P.o. Box 314
Grand Cayman E9 KY1-1104
No No Yes No
1706140 Steven Boyd C/o Armistice Capital, Llc
510 Madison Avenue, 7Th Floor
New York NY 10022
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2019-06-11 29,724 $4.39 1,066,202 No 4 S Direct
Common Stock Disposition 2019-06-11 0 $0.00 1,066,202 No 4 S Indirect See Footnote
Common Stock Disposition 2019-06-11 21,118 $4.29 1,045,084 No 4 S Direct
Common Stock Disposition 2019-06-11 0 $0.00 1,045,084 No 4 S Indirect See Footnote
Common Stock Disposition 2019-06-11 31,897 $3.30 1,013,187 No 4 S Direct
Common Stock Disposition 2019-06-11 0 $0.00 1,013,187 No 4 S Indirect See Footnote
Common Stock Acquisiton 2019-06-11 12,813 $3.80 1,026,000 No 4 P Direct
Common Stock Acquisiton 2019-06-11 0 $0.00 1,026,000 No 4 P Indirect See Footnote
Common Stock Disposition 2019-06-11 10,000 $3.64 1,016,000 No 4 S Direct
Common Stock Disposition 2019-06-11 0 $0.00 1,016,000 No 4 S Indirect See Footnote
Common Stock Disposition 2019-06-11 800 $3.61 1,015,200 No 4 S Direct
Common Stock Disposition 2019-06-11 0 $0.00 1,015,200 No 4 S Indirect See Footnote
Common Stock Disposition 2019-06-11 5,944 $3.38 1,009,256 No 4 S Direct
Common Stock Disposition 2019-06-11 0 $0.00 1,009,256 No 4 S Indirect See Footnote
Common Stock Disposition 2019-06-11 2,918 $3.17 1,006,338 No 4 S Direct
Common Stock Disposition 2019-06-11 0 $0.00 1,006,338 No 4 S Indirect See Footnote
Common Stock Disposition 2019-06-11 2,200 $3.02 1,004,138 No 4 S Direct
Common Stock Disposition 2019-06-11 0 $0.00 1,004,138 No 4 S Indirect See Footnote
Common Stock Disposition 2019-06-11 23,362 $3.01 980,776 No 4 S Direct
Common Stock Disposition 2019-06-11 0 $0.00 980,776 No 4 S Indirect See Footnote
Common Stock Disposition 2019-06-11 11,705 $3.00 969,071 No 4 S Direct
Common Stock Disposition 2019-06-11 0 $0.00 969,071 No 4 S Indirect See Footnote
Common Stock Disposition 2019-06-11 8,082 $2.91 960,989 No 4 S Direct
Common Stock Disposition 2019-06-11 0 $0.00 960,989 No 4 S Indirect See Footnote
Common Stock Disposition 2019-06-11 64,213 $2.66 896,776 No 4 S Direct
Common Stock Disposition 2019-06-11 0 $0.00 896,776 No 4 S Indirect See Footnote
Common Stock Disposition 2019-06-11 3,000 $2.53 893,776 No 4 S Direct
Common Stock Disposition 2019-06-11 0 $0.00 893,776 No 4 S Indirect See Footnote
Common Stock Disposition 2019-06-11 50,000 $2.57 843,776 No 4 S Direct
Common Stock Disposition 2019-06-11 0 $0.00 843,776 No 4 S Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Indirect See Footnote
No 4 S Direct
No 4 S Indirect See Footnote
No 4 S Direct
No 4 S Indirect See Footnote
No 4 P Direct
No 4 P Indirect See Footnote
No 4 S Direct
No 4 S Indirect See Footnote
No 4 S Direct
No 4 S Indirect See Footnote
No 4 S Direct
No 4 S Indirect See Footnote
No 4 S Direct
No 4 S Indirect See Footnote
No 4 S Direct
No 4 S Indirect See Footnote
No 4 S Direct
No 4 S Indirect See Footnote
No 4 S Direct
No 4 S Indirect See Footnote
No 4 S Direct
No 4 S Indirect See Footnote
No 4 S Direct
No 4 S Indirect See Footnote
No 4 S Direct
No 4 S Indirect See Footnote
No 4 S Direct
No 4 S Indirect See Footnote
Footnotes
  1. The reported securities are directly owned by Armistice Capital Master Fund Ltd., a Cayman Islands corporation (the "Master Fund"), and may be deemed to be indirectly beneficially owned by Armistice Capital, LLC ("Armistice Capital"), as the investment manager of the Master Fund. The reported securities may also be deemed to be indirectly beneficially owned by Steven Boyd as Managing Member of Armistice Capital. Armistice Capital and Steven Boyd disclaim beneficial ownership of the reported securities except to the extent of their respective pecuniary interest therein, and this report shall not be deemed an admission that either of them are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
  2. This constitutes the weighted average purchase price. The prices range from $3.69 to $4.05. The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.